ClinicalTrials.gov
public full text
Public Domain
Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury
Randomized, placebo controlled study to determine if nebulized heparin may reduce the severity of lung injury caused by the novel coronavirus, also known as COVID-19
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study on the Recovery of Pulmonary Function, Chest CT, Airway Microbiota, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients#857711
- A Study of Immune Responses to the Virus That Causes COVID-19#802134
- The Role of Ultrasound in COVID-19#1246171
- Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia#1294655
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome#6150
Record · ID 1375811
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive